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Abstract
Aim: This study evaluated the incidence and risk factors for intensive care and respiratory support
in infant bronchiolitis.
Methods: We carried out a retrospective descriptive case-control study on 105 patients treated in
the paediatric intensive care unit (PICU) and 210 controls treated in the emergency department or
on the paediatric ward in Tampere University Hospital in Finland between 2000-2015. Statistically
significant risk factors in non-adjusted analyses were included in the adjusted logistic regression.
Results: The average age-specific annual incidence of bronchiolitis requiring PICU admission
under the age of 12 months was 1.5/1,000/year (range 0.18-2.59). Half of those were born
prematurely at <37 gestational weeks. Other Independently significant risk factors for PICU
admission were: being less than two months old (adjusted odds ratio, aOR 11.5), birth weight
<2,000g (aOR 15.9), congenital heart disease (aOR 15.9), the presence of apnoea (aOR 7.2) and
the absence of wheezing (aOR 2.2). Significant risk factors for needing respiratory support were
birth weight of <2,000g, age of less than two months and congenital heart disease.
Conclusion: Less than 0.1% of infants under the age of 12 months were admitted to the PICU for
bronchiolitis. Low age, low birth weight or prematurity and congenital heart disease were
independently significant risk factors for both intensive care and respiratory support.
Keywords: Bronchiolitis, infant, intensive care, respiratory support, risk factors, congenital heart
disease.
Key notes
- Six per cent of infants admitted for bronchiolitis at age <12 months need intensive care and
half of them are born prematurely.
- Age less than 2 months, birth weight less than 2,000g and congenital heart disease
predicted severe bronchiolitis and need for intensive care and respiratory support in
adjusted analyses.
- Young infants with bronchiolitis, especially those with heart disease, require careful
monitoring in hospital.
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INTRODUCTION
Bronchiolitis is the most common infectious cause of hospitalisation in
infants. Most bronchiolitis patients have an uneventful course treated at
home, but about 3% of those under 24 months of age are hospitalised (1,2)
and 2% to 3% of those hospitalised need mechanical ventilation (3). A
Finnish study found that, on average, 37 per 1,000 infants aged less than
six months were admitted to the emergency department (ED) each year
due to viral bronchiolitis and 70% of them, meaning 2.6% of all infants,
were hospitalised. Furthermore, 6.1% needed treatment in the paediatric
intensive care unit (PICU), which equated to an incidence of 2.3/1,000/year
in this age-specific population (4). Another Finnish study found that the rate
of PICU treatment was 6.3% among those admitted to the ED due to
bronchiolitis at less than 12 months of age (5).
Previous studies have identified several risk factors for severe bronchiolitis
requiring hospitalisation, such as prematurity, young age, environmental
factors like passive smoking and crowded households and underlying
diseases like chronic lung disease (CLD), congenital heart disease (CHD)
and some neurological syndromes (3,6). Likewise, previous studies have
identified risk factors associated with severe bronchiolitis requiring
mechanical ventilation, such as being under two months of age, maternal
smoking during pregnancy, Caesarean section delivery, birth weight less
than 2,300g, reporting apnoea, inadequate oral intake, oxygen saturation
less than 85% in room air and respiratory rate more than 70 breaths per
minute (7-9). However, these previous prospective studies from the US
comprised infants aged more than 12 months and those with recurrent
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wheeze (7,8,10), which does not fit the current European definition of
bronchiolitis (11).
The aim of this retrospective case-control study was to evaluate the
incidence of, and the risk factors for, intensive care and respiratory support
in infants admitted to a Finnish hospital for bronchiolitis at less than 12
months of age in 2000-2015.
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PATIENTS AND METHODS
This one-centre case-control study was based on a retrospective review of
the electronic patient files of Tampere University Hospital, Tampere,
Finland, for the years 2000-2015 (12). It was carried out with the
permission of the Chief Physician of the University Hospital. At the time of
the study, the hospital provided inpatient care for a population of about
90,000 children aged less than 16 years and the population of infants aged
less than 12 months ranged from 4,761 to 5,880. In addition, the hospital
provided paediatric intensive care for the population of about 10,000 infants
aged less than 12 months from four surrounding central hospitals (12). All
the central hospitals surrounding the University Hospital had facilities to
provide non-invasive ventilation support such as nasal continuous positive
airway pressure (nCPAP) during the surveillance period. The high flow
nasal cannula (HFNC) treatment was introduced 2011 in the University
Hospital of Tampere, and HFNC treatments were given first in the PICU,
and since 2012 at the paediatric ward.
We identified all patients treated in the PICU at less than 12 months of age
with the International Classification of Diseases -10th edition (ICD-10) codes
of J10*-18*, J20*-22*, J45*or J46* during 2000-2015. We found 179 infants.
One of the authors (PH) reviewed all the 179 patient files, checked the
established diagnoses and the registered clinical findings and assessed the
final bronchiolitis diagnoses for this study. Bronchiolitis was defined as the
first episode of expiratory breathing difficulty, with or without audible
wheezing, associated with a lower respiratory tract infection (12). We
excluded infants with recurrent wheezing (n=11), blood culture-positive
bacterial infections (n=1) and tense alveolar infiltrates in chest radiographs
on admission that suggested bacterial pneumonia (n=26). Additionally, 36
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infants were treated in the PICU for some other reason than bronchiolitis.
The chart review showed that 105 infants had bronchiolitis as their main
diagnosis or treating bronchiolitis was the main reason they received
intensive care and 83 bronchiolitis patients were from Pirkanmaa
(Tampere) Hospital District. Out of the 105 cases 34 infants were treated
first on the paediatric ward and 71 were admitted directly to the PICU,
including 22 patients from other surrounding hospitals. Infants were
admitted to the PICU if they had acute worsening due the breathing such
as increasing need of supplementary oxygen or increasing of respiratory
work, or recurrent apnoea. The indications for PICU admission were the
same for infants transferred from the surrounding hospitals and for those
transferred from the wards or the ED of the University Hospital.
We selected two controls for each of these 105 cases, who were admitted
for bronchiolitis with ICD-10 codes J21* just before and after the case. The
controls were not admitted to the PICU and 146 of them were treated as
inpatients on the ward and 64 as outpatients in the ED and were not
admitted to the PICU. One of the authors (PH) reviewed the hospital
records of the 105 cases and 210 controls and completed the same
structural form to collect medical data on both groups. This was carried out
separately for findings and treatments in the ED, on the ward and in the
PICU.
The data we collected comprised information on gender, gestational age
classified with the cut-off points of 28, 32 and 37 weeks, birth weight, and
age and weight on admission for bronchiolitis. We also included the
previous medical history, such as presence of respiratory distress
syndrome (RDS), bronchopulmonary dysplasia (BPD), congenital heart
disease (CHD), treatment with surfactant as a neonate, use of inhaled
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corticosteroids later, possible previous hospital admissions including
treatment periods in the neonatal intensive care unit (NICU), presence of
atopy such as doctor-diagnosed atopic dermatitis or food allergy and family
histories of atopy or asthma. Audible wheezing, fine or coarse crackles on
auscultation and dehydration if present were recorded on admission. The
results of available viral antigen tests were collected. Secondary infections
during hospitalisation, like otitis media, conjunctivitis and pneumonia, were
recorded. Any therapies with nCPAP and mechanical ventilation were also
recorded and both were considered as a respiratory support. Apnoea was
defined as breathing pause with or without bradycardia and desaturation
detected and recorded by the medical staff.
Statistical methods
IBM SPSS Statistic 23 (SPSS Inc., Chicago, USA) was used to analyse the
data. The chi-square test and the frequency and percentage distributions
with 95% confidence intervals (95% Cl), were used in univariate statistical
calculations. The two-tailed p<0.05 was considered as statistically
significant finding. We used the Bonferroni correction by multiplying p
values by two in paired comparisons. Continuous variables were presented
as medians with interquartile ranges (IQR). Odds ratios (OR) and their 95%
Cls were calculated first as non-adjusted and then in the multivariable
logistic regression adjusted (aOR) for age, gender and risk factors that
were significant in the non-adjusted analyses. Previous hospitalisation and
previous use of corticosteroid were related to prematurity, and therefore,
they were excluded from the final multivariable analyses. Even though
several clinical findings were statistically significant in non-adjusted
analyses, we decided to choose only wheezing sound to the final
	 8
multivariable analyses due to its clear definition in the Finnish clinical
practice.
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RESULTS
The median age was 1.7 months (IQR 0.9-3.5) in the PICU bronchiolitis
group and 4.0 months (IQR 2.1-6.1) in the control bronchiolitis group
(p<0.001). Basic characteristics are presented in Table 1. Compared to the
control group, infants treated in the PICU were younger and presented with
higher comorbidities; they were born more often premature, had lower birth
weights, and previously were treated more often in the hospital (Table 1).
The risk of being admitted to the PICU was higher in infants aged less than
two months (OR 5.0, 95% Cl 3.0-8.4), born at <37 weeks (OR 7.2, 95% Cl
4.0-13.0), with birth weight under 2,500g (OR 14.6, 95% Cl 6.7-31.9), and
with apnoea (OR 39.7, 95% Cl 9.3-170.3) (Table 1).
As expected, the same characteristics were associated with the need for
respiratory support including nCPAP and/or mechanical ventilation during
the PICU stay, as were associated for the PICU admission (Table S1). The
risk for respiratory support was higher in infants aged less than two months
(OR 3.8, 95% Cl 2.0-7.2), born preterm at <37 weeks (OR 6.7, 95% Cl 3.3-
13.5), with birth weight under 2,500g (OR 8.7, 95% Cl 4.2-18.1) and CHD
(OR 5.0, 95% Cl 1.9-15.1).
Wheezing was associated with less risk of PICU admission (OR 0.3, 95%
CI 0.2-0.5) and less need for respiratory support (OR 0.4, 95% CI 0.2-0.7)
in those admitted (Table 1 and Table S1).
Apnoea was strongly associated with admission to the PICU (OR 39.7,
95% Cl 9.3-170.3) and with the need for respiratory support (OR 6.7, 95%
Cl 3.0-15.0) (Table 1 and Table S1). In fact, apnoeas were only reported in
one patient in the control group. In all, 40 infants presented with apnoea
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during the hospital stay and 40% of them needed respiratory support in the
PICU (Table S2). Statistically significant risk factors for apnoea in inpatients
were being less than two months of age (OR 5.4, 95% Cl 2.6-10.9), born
preterm at <37 weeks (OR 6.7, 95% Cl 3.2-13.7) and birth weight under
2,000g (OR 10.3, 95% Cl 4.5-23.7).
In the multivariable logistic regression, the independently significant risk
factors for PICU admission were being under two months of age (aOR
11.5, 95% CI 5.1-25.8), having low birth weight of <2,000g (aOR 15.9, 95%
CI 2.4-107.3) and presenting with CHD (aOR 15.9, 95% CI 4.2-60.5).
Reported apnoeas (aOR 7.2, 95% CI 1.4-36.1) and absence of wheezing
(aOR 2.2, 95% Cl 1.1-4.5) retained but premature birth lost the statistical
significance (Table 2).
In the multivariable logistic regression, independently significant risk factors
for the need for respiratory support, namely mechanical ventilation or
nCPAP, were being less than two months of age (aOR 10.2, 95% CI 3.0-
33.8), low birth weight of <2,000g (aOR 4.9, 95% CI 1.1-21.4) and CHD
(aOR 13.0, 95% CI 2.8-60.9). Apnoea, preterm birth and absence of
wheezing lost their statistical significance (Table 3).
Since 46% of the PICU admissions were associated with premature birth,
we performed supplementary analyses by excluding birth weight from the
model. In this model, premature birth was an independently significant risk
factor for PICU admissions (aOR 4.4, 95% CI 1.2-9.8) and respiratory
support (aOR 3.8, 95% CI 1.7-8.9).
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The annual number of the patients varied between one and 14. The mean
number of children aged less than 12 months in the population was 5,335
and varied between 4,761 and 5,880. These figures allowed us to calculate
the population-based incidences. The age-specific annual incidence varied
a lot, from 0.18/1,000/year to 2.59/1,000/year (mean 1.5) (Figure 1).
	 12	
DISCUSSION
There were four main results in this 16-year retrospective, one-centre,
case-control study on the need for intensive care in infants with bronchiolitis
at less than 12 months of age. First, the age-specific annual incidence
varied considerably, from 0.18/1,000/year to 2.59/1,000/year. Second, an
age of less than two months, birth weight under 2,000g or prematurity
under 37 weeks of gestation, and CHD were independently significant risk
factors for PICU admissions and the need for respiratory support. Third, the
presence of apnoea was associated to the need for intensive care. Fourth,
audible wheezes and coarse crackles were, interestingly, more common in
controls treated in the ED or on the ward than in cases treated in the PICU
for bronchiolitis.
A Finnish study found that the incidence of bronchiolitis admissions to the
ED at less than six months of age was 37/1,000/year and the age-specific
population-based incidence of bronchiolitis treated in the PICU was
2.3/1,000/year in that age-specific population (4). The incidence was 1.5
times higher than the mean incidence of 1.5/1,000/year in the present
study, but the annual incidence varied considerably. This variation was due
to low number of infants treated annually in the PICU and variations of
respiratory syncytial virus epidemics. The figures for the need of
mechanical ventilation among those admitted to the PICU were 13% in the
earlier study (4) and 20% in the current study. In the most recent Finnish
study, the PICU treatment rate was 6.3% among those hospitalised for
bronchiolitis at less than 12 months of age (5), but population-based
incidence figures could not be calculated in that study. In England,
admission rates to the PICU ranged from 1.3 to 1.6 per 1,000 infants at less
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than 12 months of age between 2004 and 2012 (13). These incidence
figures are surprisingly similar to the mean incidence in the present study.
In another study, based on the nationally representative database on
paediatric hospitalisations in the US, the need of mechanical ventilation
increased between 2000 and 2009 (3). Although the annual incidences
varied considerably in the present study, no such trends were seen.
Several studies have evaluated clinical factors associated with severe
bronchiolitis defined with different outcomes, such as admission to the
PICU (7,10,14-16), need for mechanical ventilation (7-9) or use of nCPAP	(17). Five studies were carried out prospectively (7-10,15). However, none
of the previous study groups were entirely comparable to our study group.
Some studies included children over 12 months old (8,10,15,16) and some
included children with episodes of previous wheezing (8,10,16,17). In
addition, some studies excluded children with an underlying disease and
preterm birth (9,14,15).
In line with our findings, PICU admissions and/or the need for respiratory
support were predicted by young age (8-10,15,16) and low birth weight
(7,8) in many studies. Two prospective multi-centre studies highlighted
being less than two months old as a risk factor for PICU admission (10) and
respiratory support (8). In the present adjusted analyses, infants who were
less than two months old had an 11.5-fold risk for PICU admission and a
10.2-fold risk for needing respiratory support. Similarly, an Italian study that
used adjusted analyses, confirmed that an age of less than one month
predicted admission to the PICU and the need for respiratory support in
hospitalised infants with bronchiolitis under the age of 12 months (9). We
found that birth weight less than 2,000g was an independently significant
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risk factor for PICU admission and respiratory support. Nearly the same
birth weight of less than 2,300g was the respective cut-off limit that
increased the risk of both intensive care and respiratory support in two
other studies (7,8).
Prematurity is a known risk factor for needing hospitalisation for severe
bronchiolitis (18,19). Only a few studies have identified premature birth as a
risk factor for PICU admission or the need for respiratory support (16). A
retrospective hospital chart review published in 2015 concluded that
premature birth was associated to PICU admission but not to the length of
PICU stay or treatment with mechanical ventilation (16). We found that
those infants with bronchiolitis who were born preterm had a 7.2-fold risk of
being admitted to the PICU and a 6.7-fold risk for needing respiratory
support. Preterm birth was an independently significant risk factor if low
birth weight was not in the multivariable model, but due to interaction, lost
its significance, if low birth weight was in the model.
CHD is associated with higher hospitalisation rates in infants with
bronchiolitis (20) and haemodynamically significant CHD is a risk factor for
severe bronchiolitis (18,21). Some earlier retrospective case-control studies
focusing on complicated RSV infections have identified CHD as a risk
factor for PICU admission, need of respiratory support, as well as long
duration of ventilation and PICU stay, in infants with bronchiolitis (22,23). In
our present retrospective 16-year case-control study all the infants with
CHD were more than 2 months of age. Finally, CHD was an independently
significant risk factor for PICU admission and for respiratory support for
infants older than 2 months, although, CHD was haemodynamically
significant in less than 25% of CHD cases.
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As expected, apnoea was an independently significant risk factor for PICU
admission. A previous prospective multi-centre study described apnoea as
an independently significant risk factor for respiratory support (8), but we
were not able to confirm that result, probably due to our retrospectively
collected data on apnoea based on entries in hospital records. In a
previous study, infants with apnoea were younger, more likely to be born
preterm and had lower birth weights (24), in accordance with our current
observations. A prospective multi-centre cohort study showed that 56% of
the 108 bronchiolitis patients with documented apnoeas during their
inpatient stay required intensive care (24). In our study, 93% of infants with
apnoeas during hospitalisation were admitted to the PICU and half of them
required respiratory support.
In the present case-control study, audible wheezes and coarse crackles
were more common among patients discharged from the ED or treated on
the ward compared to those treated in the PICU. This was in line with a
previous study on 583 children hospitalised for bronchiolitis at less than 24
months of age, which reported that wheezing was more common among
those treated on the ward (80%) than in the PICU (60%) (10). It is possible
that wheezing indicates a less invasive disease and more reactive airways
and that bronchiolitis with wheezing may be the first sign of asthma (25).
There is some indirect evidence for this assumption, since wheezing infants
seem to be older (6) and to respond better to bronchodilators (26), have
more subsequent wheezing (27) and are more likely to be associated with
viruses other than respiratory syncytial virus (25), compared to non-
wheezing infants with bronchiolitis. In particular, the first wheezing episode
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associated with rhinovirus infection may the first sign of childhood asthma
(28).
The strength of this study was were the long-term follow-up time of 16
years and carefully registered clinical data on admission and during
hospitalisation in infancy, even though it was collected retrospectively.
However, there was some information that was insufficient, such as
information about parental smoking or the non-systematic examination of
viral findings. One of the authors reviewed all the patient records after the
cases were identified from the electronic registers. This means that the
established diagnoses were not accepted directly, but were always
revisited based on the information registered in the patient records by the
doctors and nurses.
The main shortcoming of this study was that the design was retrospective.
On the other hand, organising prospective surveillance time that is long
enough including enough patients is laborious and expensive. The other
shortcoming of this one-centre study was the small number of patients,
even though the surveillance period was as long as 16 years.
CONCLUSION
The average age-specific annual incidence of bronchiolitis requiring
intensive care at the age of less than 12 months was 1.5/1000/year, but
varied considerably. The independently significant risk factors for PICU
admission and respiratory support were age less than two months, birth
weight under 2,000g or prematurity under 37 weeks and CHD.
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Table 1. Basic and clinical data presented separately for 105 infants
treated due to bronchiolitis in the paediatric intensive care unit (cases)
and for 210 controls treated due to bronchiolitis in the emergency
department or at the ward.
Characteristic Cases
n=105 (%)
Controls
n=210 (%)
OR 95% Cl p-value
Gender (males) 61 (58) 108 (51) 1.31 0.82-2.10 0.263
Age <2 months 60 (57) 44 (21) 5.0 3.00-8.38 <0.001
0-0.99 months 32 (31) 14 (7) 6.1 3.10-12.15 0.001
1-1.99 months 28 (38) 30 (15) 3.4 1.87-6.35 0.001a
2.0 months or more 45 (43) 166 (79) - - -
Prematures (<37 weeks) 45/97 (46) 22/204 (11) 7.16 3.95-12.99 <0.001
<28 weeks 12 (12) 1 (1) 28.7 3.67-223.88 0.001
28-31+6 weeks 12 (14) 1 (1) 33.2 4.24-259,87 0.001a
32-36+6 weeks 21 (22) 20 (10) 3.7 1.85-7.29 0.001a
> 37 weeks 52 (54) 182 (89) - - -
Birth weight <2500g 40/99 (40) 9/203 (4) 14.6 6.70-31.87 <0.001
<1000g 12 (12) 1 (1) 27.9 3.57-217.61 0.001
1000-1499g 8 (8) 1 (1) 20.4 2.50-165.40 0.001a
1500-1999g 7 (7) 1 (1) 19.4 2.35-160.79 0.001a
2000-2499g 13 (13) 6 (3) 7.1 2.59-19.57 0.001a
>2500 g 59 (60) 194 (96) - - -
Previous hospitalisation 57/100 (57) 34/209 (16) 6.8 3.98-11.71 <0.001
NICU 35/78 (45) 8/183 (4) 17.8 7.71-41.14 <0.001
Paediatric ward 22/65 (34) 26 (13) 3.4 1.78-6.65 <0.001
Underlying disease 27 (26) 12 (6) 5.6 2.74-11.78 <0.001
CHDb 13/89 (15) c 7/204 (3) 4.8 1.85-12.53 0.001a
BPD/RDSb 8/88 (9) 1/198 (1) 19.7 2.42-160.08 0.001a
Other relevant
diseaseb
12/91 (13) 6/203 (3) 5.0 1.81-13.75 0.002a
Atopy 3/102 (3) 8 (4) 0.7 0.20-2.95 0.696
Asthma in family 10/103 (10) 26 (16) 0.8 0.35-1.65 0.486
Current or earlier inhaled
corticosteroids
9/104 (9) 2 (1) 9.9 2.09-46.48 <0.001
Respiratory syncytial virus 59/92 (64) 66/127 (51) 1.7 0.98-2.96 0.056
Apnoea 29 (27) 2 (1) 39.7 9.25-170.33 <0.001
Tachypnea (>50/min) 36 (34) 52 (25) 1.6 0.95-2.64 0.076
Audible wheezing 39 (37) 143 (68) 0.3 0.17-0.45 <0.001
Fine crackles 26 (25) 27 (13) 2.2 1.23-4.06 0.008
Coarse crackles 33 (31) 97 (46) 0.5 0.33-0.87 0.012
Dehydration 10 (10) 8 (4) 2.7 1.91-6.95 0.022
a Bonferroni correction with multiplying the p value with 2.b Compared with patient without
underlying disease. c 7 cases with haemodynamically significant CHD. NICU, neonatal
intensive care unit; CHD, congenital heart disease; BPD, bronchopulmonary dysplasia;
RDS, respiratory distress syndrome.
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Table 2. Multivariate logistic regression: Risk factors for the need of
intensive care among 315 infants admitted for bronchiolitis in 2000–
2015.
Risk factor Adjusted Odds
ratio
95 % CI P-value
Age <2 months 11.50 5.12-25.80 <0.001
Gender (male) 1.81 0.88-3.74 0.107
Premature birth 2.19 0.85-5.62 0.105
Birth weight under
2000g
15.93 2.36-107.27 0.004
CHD 15.85 4.15-60.50 <0.001
Apnoea 7.22 1.44-36.10 0.016
Non-wheezing 2.19 1.08-4.47 0.031
Area under the curve for predicted probability: 0.882. Hosmer-Lemeshow test: 1.80, p
0.937. CHD; congenital heart disease.
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Table 3. Multivariate logistic regression: Risk factors for the need of
respiratory support among 315 infants admitted for bronchiolitis in
2000–2015.
Risk factor Adjusted Odds ratio 95 % CI P-value
Age <2 months 10.15 3.04-33.83 <0.001
Gender (male) 1.29 0.55-3.07 0.560
Premature birth 2.32 0.82-6.53 0.111
Birth weight under
2000g
4.87 1.11-21.42 0.036
CHD 12.99 2.77-60.86 0.001
Apnoea 1.62 0.51-5.14 0.416
Non-wheezing 1.44 0.57-3.65 0.440
Area under the curve for predicted probability: 0.864. Hosmer-Lemeshow test: 2.03, p
0.917. CHD; congenital heart disease.
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Supplementary Table 1. Basic and clinical data presented separately for
45 infants with bronchiolitis requiring respiratory support (nasal CPAP
and/or mechanical ventilation) treated and for 270 controls without need
for respiratory support.
Characteristic Respiratory
support
n=45 (%)
nCPAP
n=38a
Mechanical
ventilation
n=21
No respiratory
support
n=270 (%)
OR Cl 95% p-value
Gender (males) 26 (58) 22 12 143 (53) 1.2 0.64-2.30 0.549
Age <2 months 27 (60) 22 16 77 (29) 3.8 1.96-7.22 <0.001
0-0.99 months 15 (33) 9 12 31 (12) 3.9 1.87-7.95 0.001
1-1.99 months 12 (40) 10 7 46 (19) 2.8 1.26-6.21 0.018b
2 months or
more
18 (40) 16 6 193 (74) - - -
Prematures (<37 weeks) 23/40 (58) 21 10 44/261 (17) 6.7 3.30-13.51 <0.001
<28 weeks 6 (17) 6 2 7 (3) 6.4 2.03-20.18 0.001
28-31+6 weeks 6 (18) 6 2 7 (3) 7.6 2.37-24.08 0.001b
32-36+6 weeks 11 (39) 9 6 30 (12) 4.7 2.00-10.94 0.001b
>37 weeks 17 (43) 15 8 217 (83) - - -
Birth weight <2500g 21/41 (51) 19 9 28/261 (11) 8.7 4.22-18.08 <0.001
<1000g 6 (15) 6 1 7 (3) 6.2 1.98-19.57 0.001
1000-1499g 4 (11) 4 2 5 (2) 6.4 1.64-25.21 0.006b
1500-1999g 4 (13) 3 2 4 (2) 9.1 2.15-38.37 0.001b
2000-2499g 7 (26) 6 4 12 (5) 6.8 2.41-19.19 0.001b
>2500g 20 (49) 17 10 233 (89) - - -
Previous hospitalisation 25/42 (59) 16 10 66/267 (25) 4.5 2.28-8.81 <0.001
NICU 20/37 (54) 19 7 23/224 (10) 10.3 4.73-22.37 0.001b
Paediatric ward 5/22 (10) 4 4 43/244 (18) 1.4 0.48-3.93 1.102b
Underlying disease 12 (33) 12 3 27 (12) 3.3 1.51-7.05 0.002
CHD 8 (20)c 7 2 12 (6)d 5.0 1.89-15.10 <0.001b
BPD/RDS 2 (6) 2 1 7 (3) 2.0 0.41-10.24 0.752b
Other relevant
disease
4 (11) 3 1 14 (6) 2.0 0.63-6.54 0.450b
Respiratory syncytial
virus
28/41 (68) 22 14 98/178 (55) 1.8 0.90-3.78 0.094
Apnoea 14 (31) 13 10 17 (6) 6.7 3.02-14.95 <0.001
Tachypnea (>50/min) 21 (20) 20 7 67 (24) 2.7 1.39-5.07 0.002
Audible wheezing 16 (36) 13 9 166 (62) 0.4 0.18-0.67 0.001
Dehydration 4 (9) 4 1 14 (5) 1.8 0.56-5.69 0.322
a 14 infants needed both nCPAP and mechanical ventilation. bBonferroni correction with multiplying
the p value with 2. c 3 cases of  haemodynamically significant CHD. d4 cases of haemodynamically
significant CHD. nCPAP, nasal continous positive airway pressure; NICU; neonatal intensive care
unit, CHD; congenital heart disease, BPD; bronchopulmonary dysplasia, RDS; respiratory distress
syndrome.
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Supplementary Table 2. Characteristics of infants with bronchiolitis
presented separately for those 40 with apnoea and for those 275 without
apnoea during hospital stay.
Characteristic Apnoea n=40
(%)
No apnoea
n=275 (%)
OR 95% Cl p-value
Gender (males) 18 (45) 149 (54) 0.69 0.36-1.35 0.277
Age (months, median,
IQR)
1.5 (0.8-2.8) 3.5 (1.8-6.0) - - <0.001
<2 months 27 (68) 77 (28) 5.35 2.62-10.89 <0.001
0-0.99 months 11 (28) 35 (13) 2.60 1.19-5.67 0.013
1-1.99 months 16 (55) 42 (18) 5.80 2.60-12.97 0.001a
Prematures (<37 weeks) 22/38 (58) 45/263 (17) 6.66 3.24-13.68 <0.001
<28 weeks 8 (21) 5 (2) 13.76 4.23-44.76 <0.001
28-31+6 weeks 5 (17) 8 (3) 6.25 1.90-20.56 0.002a
32-36+6 weeks 9 (36) 32 (13) 3.83 1.56-9.40 0.004a
Birth weight (g, median,
IQR)
2445 (1325-
3520)
3327 (3055-
3700)
- - <0.001
<20000g 15/39 (39) 15/263 (6) 10.33 4.51-23.68 <0.001
<1000g 7 (18) 6 (2) 9.37 2.97-29.61 <0.001
1000-1499g 3 (9) 6 (2) 4.33 1.03-18.23 0.062a
1500-1999g 5 (17) 3 (1) 17.22 3.88-76.53 0.001a
Underlying disease 12 (30) 27 (10) 3.92 1.79-8.59 <0.001
CHD 4 (10) 16 (6) 1.80 0.57-5.68 0.311a
BPD/RDS 5 (15) 4 (2) 11.12 2.82-43.82 0.001a
Other relevant
disease
8 (22) 10 (4) 7.09 2.585-19.43 0.001a
Respiratory syncytial virus 21 (53) 104 (39) 1.72 0.883-3.3.57 0.108
PICU 37 (93) 68 (25) 37.54 11.218-
125.657
<0.001
Respiratory support  16 (40) 29 (11) 5.66 2.697-11.858 <0.001
nCPAP 14 (35) 24 (9) 5.54 2.67-12.01 <0.001
Intubation 10 (26) 10 (4) 9.14 3.510-23.787 <0.001
a Bonferroni correction with multiplying the p value with 2. IQR, interquartile range; CHD;
congenital heart disease, BPD; bronchopulmonary dysplasia, RDS; respiratory distress syndrome,
PICU; paediatric intensive care unit; nCPAP, nasal continuous positive airway pressure.
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Figure 1. Annual age-specific incidence of bronchiolitis infant treated in intensive care during the
study period 2000-2015.
